Brief: Cytodyn Receives Clearance From Brazil’S Anvisa To Commence Phase 3 Trial For Severe Covid-19 Patients

Cytodyn

03/08/2021 11:02

Aug 3 (Reuters) - Cytodyn Inc  CYDY.PK :
    * CYTODYN RECEIVES CLEARANCE FROM BRAZIL’S ANVISA TO
COMMENCE
PHASE 3 TRIAL FOR SEVERE COVID-19 PATIENTS
    * CYTODYN INC - EXPECTS TO CONDUCT INTERIM ANALYSIS AFTER
COMPLETION OF 40% OF ENROLLMENT
    * CYTODYN INC - ANTICIPATE THAT RESULTS OF INTERIM ANALYSIS
MAY BE
AVAILABLE IN NEXT THREE TO FOUR MONTHS USING ENDPOINTS WE
REFINED FROM CD12

Source text for Eikon:  ID:nBw335TdXa 
Further company coverage:  CYDY.PK 

 ((reuters.briefs@thomsonreuters.com;))